Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized open-label trial of lorazepam delivery sequences in mechanically ventilated pediatric intensive care patients
2019-003901-93Phase 2Completed
- Sponsor
- Ospedale Pediatrico Bambino Gesù
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of lorazepam in None and critical illness (3 arms), sponsored by Ospedale Pediatrico Bambino Gesù. Primary endpoints: Area under the concentration-time curve, Maximum plasma concentration and 5 more. Started Jan 2021; status: completed.
02
Drugs
lorazepam
03
Conditions
critical illness
Beyond the preview
Go deeper on 2019-003901-93.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003901-93.